BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Leukocyte
,
Biofuel
,
Fenofibrate
,
rs2230926
,
IL1A
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
interleukin-6 receptors
Summary
General Info
Curated Studies
Most Correlated Studies
Umbilical vein endothelial cells with IL6 siRNA knockdown treated with soluble IL6R alpha
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Diabetic Müller-Glial-Cell-Specific Il6ra Knockout Mice Exhibit Accelerated Retinal Functional Decli…
Central deficiency of IL-6Ra in mice impairs glucose-stimulated insulin secretion.
Preclinical development of CD126 CAR-T cells with broad antitumor activity.
MicroRNA-30b participates in the pathological process of hyperuricemia by regulating interleukin-6 r…
IL-6R/Signal Transducer and Activator of Transcription 3 Signaling in Keratinocytes rather than in T…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Patients With Hand Osteoarthritis
Effect of Interleukin 6 Receptor Antagonists in Corona Virus Disease 19 Patients Known by WHO
Effect of the Interleukin-6 Receptor Antagonist Tocilizumab in Non-ST Elevation Myocardial Infarctio…
Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Art…
A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ